Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
14%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
SBIO
89
HOLDINGS
16%
ALSO IN IBRN
IBRN
60
HOLDINGS
33%
ALSO IN SBIO
SECTOR DRIFT (SBIO minus IBRN)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in SBIO |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
AXSOME THERAPEUTICS, INC. | 3.2% | 3.8% | 3.2% |
|
PTC THERAPEUTICS INC | 2.4% | 4.2% | 2.4% |
 |
ALKERMES PLC | 1.9% | 3.0% | 1.9% |
|
ACADIA PHARMACEUTICALS INC | 1.9% | 3.4% | 1.9% |
|
DENALI THERAPEUTICS INC. | 1.1% | 3.1% | 1.1% |
SBIO Overweight Relative to IBRN
|
AVIDITY BIOSCIENCES INC | 4.4% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 4.0% |
|
RHYTHM PHARMACEUTICALS, INC. | 3.3% |
|
CYTOKINETICS INC | 3.1% |
 |
MERUS N.V. | 3.0% |
|
KRYSTAL BIOTECH, INC. | 2.9% |
|
NUVALENT, INC. CLASS A | 2.8% |
|
PROTAGONIST THERAPEUTICS, INC. | 2.4% |
|
VAXCYTE, INC. | 2.4% |
|
CRINETICS PHARMACEUTICALS INC | 2.1% |
SBIO Underweight Relative to IBRN
|
SCHOLAR ROCK HOLDING CORP. | -4.7% |
|
BIOGEN IDEC INC | -3.9% |
 |
ARGENX SE ADR | -3.7% |
|
CATALYST PHARMACEUTICAL PART | -3.6% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.5% |
|
NEUROCRINE BIOSCIENCES INC | -3.4% |
|
SUPERNUS PHARMACEUTICALS INC | -3.3% |
|
DYNE THERAPEUTICS INC | -2.9% |
|
SAREPTA THERAPEUTICS INC | -2.8% |
|
DENALI THERAPEUTICS INC. | -2.0% |